Strategic Governing Group - Translational Safety

Member Login

14th F2F meeting Copenhagen

2018.03.22 SGGTS

The 14th F2F meeting was held successfully in Copenhagen.


13th F2F meeting Brussels

2017.10.24 SGGTS

The 13th F2F meeting was held successfully in Brussels.


12th F2F meeting Otalampi

2017.08.14 SGGTS

The 12th F2F meeting was held successfully in Otalampi.


11th F2F meeting Darmstadt

2017.03.28 SGGTS

The 11th F2F meeting was held successfully in Darmstadt.


10th F2F meeting Montpellier

2016.10.17 SGGTS

The 10th F2F meeting was held successfully in Montpellier.


9th F2F meeting Ludwigshafen

2016.06.22 SGGTS

The 9th F2F meeting was held successfully in Ludwigshafen.


8th F2F meeting Paris

2016.04.21 SGGTS

The 8th F2F meeting was held successfully in Paris.


7th F2F meeting Basel

2015.12.10 SGGTS

The 7th F2F meeting was held successfully in Basel.


6th F2F meeting London

2015.09.29 SGGTS

The 6th F2F meeting was held successfully in London.


5th F2F meeting London

2015.06.29 SGGTS

The 5th F2F meeting was held successfully in London.


4th F2F meeting Basel

2014.12.16 SGGTS

The 4th F2F meeting was held successfully in Basel.


3rd F2F meeting Berlin

2014.12.16 SGGTS

All 19 EFPIA are to meet in Berlin to finalize their Topic Summary and further discuss their scientific interest.


SGGTS part of IMI 2

2014.10.10 SGGTS

The projects of the SGG TS will be part of a new European program, called IMI 2, which follows the Innovative Medicines Initiative (IMI) running since 2009. Like its forerunner program, IMI 2 will be a joint initiative of the European Commission (EC) and EFPIA with an overall budget of 3.27 billion Euros for seven years.


2nd F2F MEETING BRUSSELS

2014.09.10 SGGTS

All SGGTS companies conveyed in Brussels on September 10th for the 2nd F2F meeting. Based on the interest expressed by each Company representative, 3 potential Topics were selected that should lead to specific project topics to be launched by IMI call 3.


KICK OFF MEETING PARIS

2014.06.07 SGGTS

Key decision-makers in Translational Safety (TS) R&D from 16 pharma companies and representative from Innovative Medicines Initiative Joint Undertaking (IMI-JU) convened for the first time in Paris on July 7th, to launch the Strategic Governing Group Translational Safety (SGGTS).